Medikit Co.,Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medikit Co.,Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 930.2 times by its yearly operating cash. Higher than almost all Healthcare companies in Japan.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 54% of its market value (net cash). Higher than 93% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥144Over the last 3 years, every ¥100 of reported profit came with ¥144 of operating cash.
Higher than 60% of Healthcare companies in Japan.
Self-Funding Ratio
1.5×Over the last 3 years its own operating cash covered its investment spending (capex) 1.5 times.
Higher than 51% of Healthcare companies in Japan.
Cash Locked Ratio
¥30For every ¥100 of sales, ¥30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥26 tied up three years earlier.
More money tied up than 68% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥7Sales grew 10% in 3 years; of every extra ¥100 of sales, ¥7 became extra profit.
Higher than 53% of Healthcare companies in Japan.
Asset Productivity Ratio
+10% / +0%In 3 years sales changed by +10% while total assets changed by +0%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
930.2×Debt due within a year is covered 930.2 times by its yearly operating cash.
Higher than almost all Healthcare companies in Japan.
Cash Cushion Ratio
+54%Cash, after subtracting all debt, equals 54% of its market value (net cash).
Higher than 93% of Healthcare companies in Japan.
Tangible Assets Ratio
94%Of every ¥100 the company owns, ¥94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 61% of Healthcare companies in Japan.
Tangible Net Worth Ratio
94%Of every ¥100 of net worth, ¥94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 52% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Medikit Co.,Ltd. owes ¥0.12 for every ¥1 it owns. Net profit fell 0% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
12.6Investors pay ¥12.6 for every ¥1 of Medikit Co.,Ltd.'s yearly profit, lower than 65% of Healthcare companies in Japan.
P/B ratio
0.84The share price is 0.84 times Medikit Co.,Ltd.'s book value per share, lower than 83% of Healthcare companies in Japan.
Market cap
¥39.2 BThe total market value of all of Medikit Co.,Ltd.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥46.6 BWhat Medikit Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥3,222Net worth divided by the number of shares. The share price of ¥2,710 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
6.9%Medikit Co.,Ltd. earned 6.9% on its shareholders' money over the last year, lower than 53% of Healthcare companies in Japan.
Owes vs Owns
0.12×Medikit Co.,Ltd. owes ¥0.12 for every ¥1 it owns (low), lower than 90% of Healthcare companies in Japan.
Dividend yield
3.72%Medikit Co.,Ltd. pays 3.72% of its share price as dividends a year, higher than 78% of dividend-paying Healthcare companies in Japan.
Revenue growth
+5%Revenue rose 5% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Profit growth
-0%Net profit fell 0% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Profit margin
12.6%Medikit Co.,Ltd. keeps ¥13 of every ¥100 of revenue as net profit.
Cash quality
1.6×Cash from Medikit Co.,Ltd.'s business was 1.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
557.3×Medikit Co.,Ltd.'s operating profit covered its interest costs 557.3 times in the year to Mar 2026.
Cash vs debt
Net cashMedikit Co.,Ltd. held ¥20.9 B more cash than debt (net cash) at Mar 2026.
Questions
What is Medikit Co.,Ltd.'s P/E ratio?
Investors pay ¥12.6 for every ¥1 of Medikit Co.,Ltd.'s yearly profit, lower than 65% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medikit Co.,Ltd.: ¥39.2 B ÷ ¥46.6 B (30 Jun 2026) = 0.8.
What is Medikit Co.,Ltd.'s return on equity?
Medikit Co.,Ltd. earned 6.9% on its shareholders' money over the last year, lower than 53% of Healthcare companies in Japan.
How much does Medikit Co.,Ltd. owe compared with what it owns?
Medikit Co.,Ltd. owes ¥0.12 for every ¥1 it owns (low), lower than 90% of Healthcare companies in Japan.
Does Medikit Co.,Ltd. pay a dividend?
Yes. Medikit Co.,Ltd. pays 3.72% of its share price as dividends a year, higher than 78% of dividend-paying Healthcare companies in Japan.
Is Medikit Co.,Ltd.'s revenue growing?
Revenue rose 5% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.